Skip to main content

Year: 2025

SYLOGIST Reports Third Quarter 2025 Results

Delivers 12% SaaS revenue growth and 19% Adjusted EBITDA Margin Q3 2025 Financial Highlights  Revenue (in $ millions)  SaaS Subscription Recurring TotalReported Y/Y growth Reported Y/Y growth Reported Y/Y growth$8.3 11.9% $11.4 5.0% $15.9 (4.2)% SaaS ARR up 15% year over year to $33.6 million; Total ARR up 5% year over year to $45.8 million; SaaS NRR of 106%; ARR Bookings of $1.0 million; Total Contract Value of Bookings at $5.9 million; Adjusted EBITDA Margin of 19.3% or $3.1 million; Net income (loss) of $(0.9) million Gross profit margin of 60%; and Recurring revenue at 72% of total revenue.CALGARY, Alberta, Nov. 06, 2025 (GLOBE NEWSWIRE) — Sylogist Ltd. (TSX: SYZ) (“Sylogist” or the “Company”), a leading public sector SaaS company, today announced its results for the third quarter...

Continue reading

CLEAR Announces Third Quarter 2025 Financial Results

NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) — Clear Secure, Inc. (NYSE: YOU), the secure identity company, has released financial results for the third quarter of fiscal year of 2025 on its Investor Relations website at https://ir.clearme.com. Third Quarter Financial Highlights(percentage change is expressed as year-over-year, unless otherwise specified)Revenue of $229.2 million was up 15.5%; Total Bookings of $260.1 million were up 14.3% Operating income of $52.6 million, representing a 23.0% Operating income margin Net income of $45.1 million, representing a 19.7% net income margin; Adjusted EBITDA of $70.1 million, representing a 30.6% Adjusted EBITDA margin Earnings per Common Share Basic and Diluted of $0.29 and $0.29 Net cash used in operating activities of $(47.3) million; Free Cash Flow of $(53.5) million; both figures reflect...

Continue reading

First Advantage Reports Third Quarter 2025 Results

Delivers Strong Third Quarter Results and Refines Full Year 2025 Guidance Third Quarter 2025 Highlights1Revenues of $409.2 million Net Income of $2.6 million, a net income margin of 0.6%, includes $6.3 million of expenses related to the acquisition of Sterling Check Corp. (“Sterling”) and related integration, and $41.7 million of Sterling acquisition depreciation and amortization Adjusted Net Income of $52.3 million Adjusted EBITDA of $118.5 million; Adjusted EBITDA Margin of 29.0% GAAP Diluted Net Income Per Share of $0.01, includes $0.03 per share of expenses incurred related to the Sterling acquisition and related integration Adjusted Diluted Earnings Per Share of $0.30 Cash Flows from Operations of $72.4 million; Adjusted Operating Cash Flows of $80.5 million, after adjusting for $8.1 million of cash costs directly associated with...

Continue reading

LifeStance Reports Third Quarter 2025 Results

SCOTTSDALE, Ariz., Nov. 06, 2025 (GLOBE NEWSWIRE) — LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation’s largest providers of outpatient mental healthcare, today announced financial results for the third quarter ended September 30, 2025. (All results compared to prior-year comparative period, unless otherwise noted)Q3 2025 Highlights and FY 2025 OutlookRevenue of $363.8 million increased 16% compared to revenue of $312.7 million Clinician base increased 11% to 7,996 clinicians, a sequential net increase of 288 in the third quarter Third quarter visit volumes increased 17% to 2.3 million Net income of $1.1 million compared to net loss of $6.0 million Adjusted EBITDA of $40.2 million increased 31% compared to Adjusted EBITDA of $30.7 million Net cash provided by operations of $27.3 million in the third quarter resulting...

Continue reading

Enerflex Ltd. Announces Third Quarter 2025 Financial and Operational Results and Increased Dividend

RECORD ADJUSTED EBITDA AND RETURN ON CAPITAL EMPLOYED FREE CASH FLOW OF $43 MILLION STRONG OPERATIONAL VISIBILITY WITH ES AND EI BACKLOG OF $1.1 BILLION AND $1.4 BILLION, RESPECTIVELY QUARTERLY DIVIDEND INCREASE TO CAD$0.0425 PER SHARE SUPPORTS DIRECT SHAREHOLDER RETURNS CALGARY, Alberta, Nov. 06, 2025 (GLOBE NEWSWIRE) — Enerflex Ltd. (TSX: EFX) (NYSE: EFXT) (“Enerflex” or the “Company”) today reported its financial and operational results for the three and nine months ended September 30, 2025. All amounts presented are in U.S. Dollars unless otherwise stated. Q3/25 FINANCIAL OVERVIEWGenerated revenue of $777 million compared to $601 million in Q3/24 and $615 million in Q2/25.Higher revenue is primarily attributable to commencement of the Block 60 Bisat-C Expansion Facility (“Bisat-C Expansion”) located in the Eastern Hemisphere...

Continue reading

Prestige Consumer Healthcare Inc. Reports Second Quarter and First Half Fiscal 2026 Results

Revenue of $274.1 million in Q2, ahead of outlook Diluted EPS of $0.86 in Q2 and Adjusted Diluted EPS of $1.07, versus prior year Q2 Diluted EPS of $1.09 Repurchased approximately 1.1 million shares opportunistically in Q2 Fiscal 2026 revenue outlook unchanged; Adjusted Diluted EPS outlook updated to $4.54 to $4.58, high end of previous rangeTARRYTOWN, N.Y., Nov. 06, 2025 (GLOBE NEWSWIRE) — Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its second quarter and first six months ended September 30, 2025. “Our second quarter results surpassed our sales and earnings expectations helped primarily by Clear Eyes® supply timing and the timing of certain retailer orders. We remain pleased with the performance of the remainder of our business, where we continue to focus on brand-building behind our diverse...

Continue reading

Privia Health Reports Third Quarter 2025 Financial Results

Very Strong Third Quarter and Year-to-Date Performance Across the Business Net Income +94.1% and Adjusted EBITDA +61.6% compared to 3Q’24 Implemented Providers +13.1% and Practice Collections +27.1% compared to 3Q’24 FY’25 Guidance Raised Above High End for All Key Operating and Financial MetricsARLINGTON, Va., Nov. 06, 2025 (GLOBE NEWSWIRE) — Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial results for the third quarter ended September 30, 2025. Third Quarter Performance    For the Three Months Ended September 30,    ($ in millions, except per share amounts)     2025     2024   Change (%) fTotal revenue   $ 580.4   $ 437.9   32.5 %Gross profit   $ 122.6   $ 99.9   22.7 %Operating income   $ 14.4   $ 5.8   147.8 %Net income a   $ 6.9   $ 3.5   94.1 %Non-GAAP adjusted net income b d e   $ 37.3   $ 25.1   49.1 %Net...

Continue reading

Millicom (Tigo) Q3 2025 Earnings Release

Millicom (Tigo) Q3 2025 Earnings Release Luxembourg, November 6, 2025 – Millicom is pleased to announce its third quarter 2025 results. Please find below links to the Q3 2025 Earnings Release and IAS 34 Interim Condensed Consolidated Financial Statements. Q3 2025 Highlights*Revenue $1.42 billionOperating profit $390 million, and record Adjusted EBITDA $695 millionNet profit attributable to company owners $195 million, including approximately $138 million net profit from the closure of infrastructure transactionsEquity free cash flow $243 millionAdditional interim dividend declared in August of $2.5 per share, amounting approximately $420 million Leverage of 2.09x, benefiting from one-time cash proceeds of $537 million from infrastructure transactions Financial highlights ($ millions) Q3 2025 Q3 2024 ...

Continue reading

Tejon Ranch Co. Announces Third Quarter 2025 Financial Results

TEJON RANCH, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) — Tejon Ranch Co., or the Company, (NYSE:TRC), a diversified real estate development and agribusiness company, today announced financial results for the three and nine-months ended September 30, 2025. Third Quarter 2025 Financial and Operating HighlightsGAAP net income attributable to common stockholders for the third quarter of 2025 was $1.7 million, or net income per share attributable to common stockholders, basic and diluted, of $0.06. In the third quarter of 2024, the Company reported net loss attributable to common stockholders of $1.8 million, or net loss per share attributable to common stockholders, basic and diluted, of $0.07. This represents a positive change of $3.5 million in net income and an improvement of $0.13 per share compared to the same quarter last year. Revenues...

Continue reading

Enovis Announces Third Quarter 2025 Results

Diversified growth platform delivers third-quarter sales growth of 9% on a reported basis, 7% organicallyThird-quarter Reconstructive sales grew 12% year-over-year on a reported basis, 9% organicallyOctober divestiture of Diabetic Footcare business unit from P&R for total proceeds of up to $60 millionRaising full-year 2025 adjusted EBITDA and adjusted EPS guidanceDallas, TX, Nov. 06, 2025 (GLOBE NEWSWIRE) — Enovis™ Corporation (“Enovis” or “the Company”) (NYSE: ENOV), an innovation-driven medical technology growth company, today announced its financial results for the third quarter ended October 3, 2025. The Company will host an investor conference call and live webcast to discuss these results today at 8:30 am ET. Third Quarter 2025 Financial Results Enovis’ third-quarter net sales of $549 million grew...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.